Sean Duffy, Omada Health CEO
June 5, 2025 08:40 PM EDTUpdated 10:11 PM
Financing
Health Tech

Oma­da Health is go­ing pub­lic at a $1.1B val­u­a­tion

Ngai Yeung

Health Tech Reporter

Oma­da Health priced its shares in the mid­dle of its in­di­cat­ed range at $19 each, valu­ing it at around $1.1 bil­lion.

It plans to start …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

COO / Head of Operations (Stealth Portfolio Company)‬ ‭

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

Biotech ranks as Chi­na’s best shot to sur­pass US in emerg­ing tech, re­port finds

Is there still hope for Sum­mit's can­cer drug buried in the da­ta?

GSK taps Sanofi vet to lead vac­cine R&D; Bris­tol My­ers names head of cor­po­rate af­fairs

MIT sci­en­tists’ AI mod­el one-ups Al­phaFold 3, takes on ‘fun­da­men­tal is­sue’ in drug R&D

Ot­su­ka spells out Phase 3 win in rare kid­ney dis­ease, Ve­ra’s stock takes a hit

sponsored

Cy­ti­va and Eu­rek­aBio form strate­gic part­ner­ship to ad­vance lentivi­ral vec­tor man­u­fac­tur­ing for cell and gene ther­a­py ...

A service from the Financial Times